Latest Conference Articles

The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.

José-Alain Sahel, MD: Safety, Efficacy of Optogenetic Treatment for Retinitis Pigmentosa

José-Alain Sahel, MD: Safety, Efficacy of Optogenetic Treatment for Retinitis Pigmentosa

November 19th 2021, 7:00pm

American Academy of Ophthalmology

At AAO 2021, Dr. Sahel discussed the findings of the PIONEER trial on the combination of an optogenetics device and gene therapy in treatment of RP.

Robert L. Avery, MD Highlights Results on RGX-314 For the Treatment Of Wet AMD

Robert L. Avery, MD Highlights Results on RGX-314 For the Treatment Of Wet AMD

November 17th 2021, 8:00pm

American Academy of Ophthalmology

Dr. Avery discusses the positive results of RGX-314 gene therapy, noting dramatic reduction in need for therapy, with stable vision and good thickness results

Dilsher S. Dhoot, MD: Efficacy of Brolucizumab in Treatment of Diabetic Macular Edema

Dilsher S. Dhoot, MD: Efficacy of Brolucizumab in Treatment of Diabetic Macular Edema

November 16th 2021, 10:00pm

American Academy of Ophthalmology

Dr. Dhoot discusses data on visual acuity from the phase 3 KESTREL and KITE trials, comparing brolucizumab to aflibercept at 52 weeks.

Abrocitinib Dosing Effective in Atopic Dermatitis Management

Abrocitinib Dosing Effective in Atopic Dermatitis Management

November 16th 2021, 9:00pm

Derm Fall Clinical

Investigators said that patient-reported outcomes from the 2 abrocitinib groups showed greater efficacy than the dupilumab and placebo groups.

Study Evaluates Sun Protection Awareness in Adolescents

Study Evaluates Sun Protection Awareness in Adolescents

November 16th 2021, 5:00pm

Derm Fall Clinical

Respondents suggested that increasing product availability and demonstrating the consequences of sunburn could increase sun protection among young people.

Arshad Khanani, MD Discusses Adverse Ocular Events After Brolucizumab Treatment

Arshad Khanani, MD Discusses Adverse Ocular Events After Brolucizumab Treatment

November 16th 2021, 4:00pm

American Academy of Ophthalmology

Dr. Khanani highlights data from MERLIN showing noninferiority of brolucizumab to aflibercept in nAMD treatment, but a higher rate of intraocular inflammation.

Veeral Sheth, MD: Identifying Durability, Safety of GB-102 in Wet AMD Treatment

Veeral Sheth, MD: Identifying Durability, Safety of GB-102 in Wet AMD Treatment

November 16th 2021, 1:00pm

American Academy of Ophthalmology

Dr. Sheth discusses the data from the late-breaking Phase 2B ALTISSIMO study.

Boni Elewski, MD: Biologics for Pediatric Psoriasis Patients

Boni Elewski, MD: Biologics for Pediatric Psoriasis Patients

November 15th 2021, 10:00pm

Derm Fall Clinical

Dr. Elewski hopes that in the future more clinicians will prescribe biologics such as secukinumab and etancercept for the treatment of psoriasis.

Lisa Swanson, MD: Detailing Infantile Hemangioma

Lisa Swanson, MD: Detailing Infantile Hemangioma

November 15th 2021, 9:00pm

Derm Fall Clinical

Though not all hemangioma last past 10 years old in pediatric patients, some untreated hemangioma are associated with high risk of ulceration.

Saakshi Khattri,MD: Evolving Therapies for Psoriatic Disease

Saakshi Khattri,MD: Evolving Therapies for Psoriatic Disease

November 15th 2021, 8:00pm

Derm Fall Clinical

Though Dr. Khattri felt the diagnosis of psoriatic arthritis had been “stagnant”, the inclusion of biologic therapies and more has been a welcomed change.